These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1511063)

  • 21. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in genetic changes between multiple myeloma and plasma cell leukemia demonstrated by comparative genomic hybridization.
    Gutiérrez NC; Hernández JM; García JL; Cañizo MC; González M; Hernández J; González MB; Garciá-Marcos MA; San Miguel JF
    Leukemia; 2001 May; 15(5):840-5. PubMed ID: 11368447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-random chromosomal aberrations associated with multiple myeloma.
    Lewis JP; MacKenzie MR
    Hematol Oncol; 1984; 2(4):307-17. PubMed ID: 6335483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia.
    Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I
    Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal and in vitro culture studies in a case of primary plasma cell leukemia.
    Pérez Losada A; Woessner S; Solé F; Florensa L; Bonet C
    Cancer Genet Cytogenet; 1994 Aug; 76(1):36-8. PubMed ID: 8076348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
    Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
    Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetics of multiple myeloma.
    Trcić RL; Skelin IK; Sustercić D; Planinc-Peraica A; Ajduković R; Haris V; Kusec R; Begović D
    Coll Antropol; 2010 Mar; 34(1):41-4. PubMed ID: 20432732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Marker-chromosome 14 in multiple myeloma and plasma-cell leukaemia.
    Wurster-Hill DH; McIntyre OR; Cornwell GG; Maurer LH
    Lancet; 1973 Nov; 302(7836):1031. PubMed ID: 4127256
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined cytogenetic testing and fluorescence in situ hybridization analysis in the study of chronic lymphocytic leukemia and multiple myeloma.
    Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Aug; 153(1):73-6. PubMed ID: 15325099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
    Schilling G; Dierlamm J; Hossfeld DK
    Hematol Oncol; 2005; 23(3-4):102-7. PubMed ID: 16342296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of plasma cell leukemia. Clinical and cytogenetic observations].
    Balogh E; Fleischmann T; Krizsa F
    Orv Hetil; 1985 Oct; 126(41):2531-3. PubMed ID: 3863083
    [No Abstract]   [Full Text] [Related]  

  • 32. Chromosomes in plasma-cell malignancies.
    Van Den Berghe H
    Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: correlation with survival.
    Lisse IM; Drivsholm A; Christoffersen P
    Cancer Genet Cytogenet; 1988 Oct; 35(1):27-36. PubMed ID: 3180005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
    Jonveaux P; Berger R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
    Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
    Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
    Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
    Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
    Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
    Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment.
    Pérez-Andrés M; Almeida J; Martín-Ayuso M; Moro MJ; Martín-Nuñez G; Galende J; Borrego D; Rodríguez MJ; Ortega F; Hernandez J; Moreno I; Domínguez M; Mateo G; San Miguel JF; Orfao A; ;
    Leukemia; 2005 Mar; 19(3):449-55. PubMed ID: 15674420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma.
    Clark RE; Geddes AD; Whittaker JA; Jacobs A
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1789-93. PubMed ID: 2632260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.